AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
7.92
-0.22 (-2.70%)
Apr 1, 2025, 10:21 AM EDT - Market open
AVITA Medical Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$17.25
Upside
+117.80%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $22 | Strong Buy | Maintains | $22 | +177.78% | Mar 18, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 → $22 | Strong Buy | Maintains | $25 → $22 | +177.78% | Feb 20, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +215.66% | Feb 14, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $20 → $14 | Strong Buy | Maintains | $20 → $14 | +76.77% | Jan 8, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +215.66% | Jan 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $21 | Buy | Reiterates | $21 | +165.15% | Dec 24, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +215.66% | Dec 24, 2024 |
| Piper Sandler | Piper Sandler | Hold Reiterates $9 → $12 | Hold | Reiterates | $9 → $12 | +51.52% | Nov 8, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $21 | Buy | Reiterates | $21 | +165.15% | Aug 9, 2024 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $21 → $9 | Buy → Hold | Downgrades | $21 → $9 | +13.64% | May 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $22 → $21 | Buy | Maintains | $22 → $21 | +165.15% | May 14, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 11, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $19 → $21 | Buy | Reiterates | $19 → $21 | +165.15% | Feb 23, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $22 → $25 | Buy | Maintains | $22 → $25 | +215.66% | Feb 23, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $20 → $22 | Buy | Maintains | $20 → $22 | +177.78% | Jan 19, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $20 | Buy | Reiterates | $20 | +152.53% | Nov 21, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.